Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by PROtradingon May 12, 2016 10:59am
98 Views
Post# 24865985

RE:Q1

RE:Q1Hey known paid basher!  Expectations?  Expectations from the way VRX is trading is that it's closing its doors tomorrow! LOL  Which it isn't!!!  All that negativity is baked into the price, "Angie"!  Nice isn't it!!!! :-)

You get paid much to be a crook?   Do you sleep well at night?  Are you generally unlucky in life? :-)  LOL

Lattice wrote: Senate document dump shows Valeant booked Jan $571M and Feb $689M.  
So March revs have to be $1 billion to meet expectations?  That's gonna be tough, no?


<< Previous
Bullboard Posts
Next >>